RCAMU
UTHR icon

Rothschild & Co Asset Management US’s United Therapeutics UTHR Stock Holding History

Rothschild & Co Asset Management US’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-77,587
Closed -$10.5M – 589
2017
Q1 		$10.5M Buy
77,587
+2,917
+4% +$442K 0.12% 238
2016
Q4 		$10.7M Sell
74,670
-18,209
-20% -$2.32M 0.14% 226
2016
Q3 		$11M Buy
92,879
+7,292
+9% +$876K 0.19% 202
2016
Q2 		$9.06M Buy
85,587
+14,058
+20% +$1.57M 0.16% 215
2016
Q1 		$7.97M Sell
71,529
-7,382
-9% -$934K 0.15% 211
2015
Q4 		$12.4M Sell
78,911
-54,071
-41% -$7.87M 0.23% 148
2015
Q3 		$17.5M Sell
132,982
-204
-0.2% -$32.7K 0.34% 96
2015
Q2 		$23.2M Sell
133,186
-40,074
-23% -$7.21M 0.43% 65
2015
Q1 		$29.9M Sell
173,260
-26,804
-13% -$4.09M 0.57% 46
2014
Q4 		$26M Buy
200,064
+111,108
+125% +$14.3M 0.52% 54
2014
Q3 		$11.4M Sell
88,956
-3,820
-4% -$394K 0.24% 124
2014
Q2 		$8.21M Sell
92,776
-429
-0.5% -$41.3K 0.17% 205
2014
Q1 		$8.76M Buy
93,205
+22,937
+33% +$2.35M 0.2% 188
2013
Q4 		$7.95M Buy
70,268
+1,593
+2% +$144K 0.18% 209
2013
Q3 		$5.42M Buy
68,675
+2,700
+4% +$197K 0.12% 258
2013
Q2 		$4.34M Buy
+65,975
New +$4.25M 0.1% 277

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rothschild & Co Asset Management US's UTHR Position: Q2 2017 in Review

Rothschild & Co Asset Management US sold out of United Therapeutics (UTHR) in Q2 2017, closing a stake of 77,587 shares — an estimated $10.5M sold.

Rothschild & Co Asset Management US first reported a position in UTHR in Q2 2013 and held it in 16 quarters. The position peaked at $29.9M in Q1 2015. 373 funds tracked by Wall St. Rank hold UTHR as of Q2 2017.

  • Rothschild & Co Asset Management US reported no remaining United Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 77,587 United Therapeutics shares in Q2 2017, an estimated $10.5M.
  • Rothschild & Co Asset Management US first reported a position in United Therapeutics in Q2 2013 and held it in 16 quarters.
  • Rothschild & Co Asset Management US's United Therapeutics position peaked at $29.9M in Q1 2015.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2017, filed 27 Jul 2017.